The mortality benefit of carvedilol versus bisoprolol in patients with heart failure with reduced ejection fraction-Reference-Cited by-同舟云学术

The mortality benefit of carvedilol versus bisoprolol in patients with heart failure with reduced ejection fraction

Published:2019-09-01 Issue:5 Volume:34 Page:1030-1039
ISSN:1226-3303
Container-title:The Korean Journal of Internal Medicine
language:en
Short-container-title:Korean J Intern Med

Author:

Choi Ki Hong,Lee Ga Yeon,Choi Jin-Oh,Jeon Eun-Seok,Lee Hae-Young,Lee Sang Eun,Kim Jae-Joong,Chae Shung Chull,Baek Sang Hong,Kang Seok-Min,Choi Dong-Ju,Yoo Byung-Su,Kim Kye Hun,Cho Myeong-Chan,Park Hyun-Young,Oh Byung-Hee

Funder

Korea Centers for Disease Control & Prevention

Publisher

Korean Association of Internal Medicine

Link

http://kjim.org/upload/kjim-2018-009.pdf

Reference27 articles.

1. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure

2. 2013 ACCF/AHA Guideline for the Management of Heart Failure

3. The Effect of Carvedilol on Morbidity and Mortality in Patients with Chronic Heart Failure

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Korean Society of Heart Failure Guidelines for the Management of Heart Failure: Treatment;Korean Circulation Journal;2023

2. Korean Society of Heart Failure Guidelines for the Management of Heart Failure: Treatment;International Journal of Heart Failure;2023

3. Reviewing the Modern Therapeutical Options and the Outcomes of Sacubitril/Valsartan in Heart Failure;International Journal of Molecular Sciences;2022-09-26

4. Exploring the kinetic selectivity of drugs targeting the β ₁ ‐adrenoceptor;Pharmacology Research & Perspectives;2022-06-28

5. Perspective on the Role of Four Beta-blockers in Heart Failure;Current Reviews in Clinical and Experimental Pharmacology;2021-10-29